diacomit 500mg
laboratoires biocodex - franta - stiripentolum - caps. - 500mg - antiepileptice alte antiepileptice
diacomit 500mg
laboratoires biocodex - franta - stiripentolum - pulb. pt. susp. orala - 500mg - antiepileptice alte antiepileptice
diacomit 250mg capsules
alan pharmaceuticals - stiripentol - capsule - 250mg
diacomit 250mg oral powder sachets
alan pharmaceuticals - stiripentol - powder - 250mg
diacomit 500mg capsules
alan pharmaceuticals - stiripentol - capsule - 500mg
diacomit 500mg oral powder sachets
alan pharmaceuticals - stiripentol - powder - 500mg
diacomit capsules 250mg (ディアコミットカプセル250mg)
meiji seika pharma co., ltd. - stiripentol - bright purplish red capsule, major axis: 18.1 mm, minor axis: 6.1 mm
diacomit drysyrup 250mg (ディアコミットドライシロップ分包250mg)
meiji seika pharma co., ltd. - stiripentol - very light reddish white granules
diacomit drysyrup 500mg (ディアコミットドライシロップ分包500mg)
meiji seika pharma co., ltd. - stiripentol - very light reddish white granules
epidyolex cannabidiol 100 mg/ml oral liquid solution bottle
chiesi australia pty ltd - cannabidiol, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sesame oil; sucralose; ethanol absolute; flavour - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.